Colby Group
University of Mississippi
Home Research Group David A. Colby Publications Patents Teaching Contact Funding
Publications

Colby Laboratory



42. “Synthesis of Difluorinated Halohydrins by the Chemoselective Addition of Difluoroenolates to α-Haloketones.” Sowaileh, M. F.; Alshammari, M. D.; Colby, D. A. Org. Lett. 2021, 23, 5098–5101. DOI:10.1021/acs.orglett.1c01636




41. “Synthesis, Biological Evaluation, and NMR Studies of 3-Fluorinated Derivatives of 3',4',5'-Trihydroxyflavone and 3',4',5'-Trimethoxyflavone.” Alshammari, M. D.; Kucheryavy. P. V.; Ashpole, N. M.; Colby, D. A. Bioorg. Med. Chem. Lett. 2021, 32, 127720. DOI:10.1016/j.bmcl.2020.127720




40. “Synthesis of β-Fluoro-α,β-Unsaturated Amides from the Fragmentation of Morpholine 3,3,3-Trifluoropropanamide by Grignard Reagents.” Adam, A. T.; Fronczek, F. R.; Colby, D. A. Org. Lett. 2020, 7, 2630–2633. DOI:10.1021/acs.orglett.0c00599




39. “Controlling the Cleavage of Carbon–Carbon Bonds to Generate α,α-Difluorobenzyl Carbanions for the Construction of Difluoromethylbenzenes.” Khatri, H. R.; Han, C.; Luong, E.; Pan, X.; Adam, A. T.; Alshammari, M. D.; Shao, Y.; Colby, D. A. J. Org. Chem. 2019, 84, 11665–11675. DOI:10.1021/acs.joc.9b01595




38. “Fluoroenolate-Enabled Monofluorinations and Difluoromethylations.” Sowaileh, M. F.; Colby, D. A. Aldrichimica Acta 2018, 51, 47–59. link




37. “Agonists of the γ-Aminobutyric Acid Type B (GABAB) Receptor Derived from β-Hydroxy and β-Amino Difluoromethyl Ketones.” Sowaileh, M. F.; Salyer, A. E.; Roy, K. K.; John, J. P.; Woods, J. R.; Doerksen, R. J.; Hockerman, G. H.; Colby, D. A. Bioorg. Med. Chem. Lett. 2018, 28, 2697–2700. DOI:10.1016/j.bmcl.2018.04.003




36. “Magnesium-Promoted Additions of Difluoroenolates to Unactivated Imines.” Nguyen, A. L.; Khatri, H. R.; Woods, J. R.; Baldwin, C. S.; Fronczek, F. R.; Colby, D. A. J. Org. Chem. 2018, 83, 3109–3118. DOI:10.1021/acs.joc.7b03014




35. “Energy Drinks Adverse Effects: What is Being Done to Protect Public Health.” Thorlton, J.; Colby, D. A. Western J. Nurs. Res. 2018, 40, 3–4. DOI:10.1177/0193945917731994




34. “Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.” Sowaileh, M. F.; Hazlitt, R. A.; Colby, D. A. ChemMedChem 2017, 12, 1481–1490. DOI:10.1002/cmdc.201700356
      • Most accessed article for October 2017
      • Included in MedChem in the USA issue link




33. “Generation of Magnesium Pentafluoropropen-2-olate from Hexafluoroisopropanol and Synthesis of 2,2,4,4,4-Pentafluoro-3,3-dihydroxyketones.” Hazlitt, R. A.; Tran, Q. -L.; Sowaileh, M. F.; Colby, D. A. J. Org. Chem. 2017, 82, 2231–2236. DOI:10.1021/acs.joc.6b02863




32. “Conversion of Methyl Ketones and Methyl Sulfones into α-Deutero-α,α-difluoromethyl Ketones and α-Deutero-α,α-difluoromethyl Sulfones in Three Synthetic Steps.” Sowaileh, M. F.; Han, C.; Hazlitt, R. A.; Kim, E. H.; John, J. P.; Colby, D. A. Tetrahedron Lett. 2017, 58, 396–400. DOI:10.1016/j.tetlet.2016.12.018




31. “15-Methylene-Eburnamonine Kills Leukemic Stem Cells and Reduces Engraftment in a Humanized Bone Marrow Xenograft Mouse Model of Leukemia.” Gunasekara, D. C.; Zheng, M. M.; Mojtahed, T.; Woods, J. R.; Fandy, T. E.; Riofksi, M. V.; Glackin, C. A.; Hassan, H. E.; Kirsher, J.; Colby, D. A. ChemMedChem 2016, 11, 2392–2397. DOI:10.1002/cmdc.201600334
      • Included in MedChem in the USA issue link




30. “Optimized Synthesis of a Pentafluoro-gem-diol and Conversion to a CF2Br-Glucopyranose through Trifluoroacetate-Release and Halogenation.” Hazlitt, R. A.; John, J. P.; Tran, Q. -L.; Colby, D. A. Tetrahedron Lett. 2016, 57, 1906–1908. DOI:10.1016/j.tetlet.2016.03.064




29. “Energy Drinks: Implications for the Breast Feeding Mother.” Thorlton, J.; Ahmed, A.; Colby, D. A. Am. J. Matern. Child Nurs. 2016, 41, 179–185. DOI:10.1097/NMC.0000000000000228




28. “In Vitro Characterization of Transport and Metabolism of the Alkaloids: Vincamine, Vinpocetine and Eburnamonine.” Fandy, T. E.; Abdallah, I.; Khayat, M.; Colby, D. A.; Hassan, H. E. Cancer Chemother. Pharmacol. 2016, 77, 259–267. DOI:10.1007/s00280-015-2924-3




27. “Activation of the γ-Aminobutyric Acid Type B (GABAB) Receptor by Agonists and Positive Allosteric Modulators.” Brown, K. M.; Roy, K. K.; Hockerman, G. H.; Doerksen, R. J.; Colby, D. A. J. Med. Chem. 2015, 58, 6336–6347. DOI:10.1021/jm501893




26. “Effect of Substituents and Stability of Transient Aluminum-Aminals in the Presence of Nucleophiles.” Barrios, F. J.; Springer, B. C.; Hazlitt, R. A.; Colby, D. A. Synthesis 2015, 47, 175–180. DOI:10.1055/s-0034-1379635
      • Feature Article and made the cover






25. “Proposed Actions for the U.S. Food & Drug Administration To Implement To Minimize Adverse Effects Associated with Energy Drink Consumption.” Thorlton, J.; Colby, D. A.; Devine, P. Am. J. Public Health 2014, 104, 1175–1180. DOI:10.2105/ajph.2014.301967




24. “Synthesis of 15-Methylene-eburnamonine from (+)-Vincamine, Evaluation of Anticancer Activity, and Investigation of Mechanism of Action.” Woods, J. R.; Riofski, M. V.; Zheng, M. M.; Mo, H.; Kirshner, J.; Colby, D. A. Bioorg. Med. Chem. Lett. 2013, 23, 5865–5869. DOI:10.1016/j.bmcl.2013.08.095




23. “Control of Transient Aluminum-Aminals for Masking and Unmasking Carbonyl Groups.” Barrios, F. J.; Springer, B. C.; Colby, D. A. Org. Lett. 2013, 15, 3082–3085. DOI:10.1021/ol401265a
      • highlighted in Synfacts 2013, 9, 990. DOI:10.1055/s-0033-1339558
      • highlighted in Org. Chem. Highlights 2013, November 11. link




22. “Evaluation of Difluoromethyl Ketones as Agonists of the gamma-Aminobutyric Acid Type B (GABAB) Receptor.” Han, C.; Salyer, A. E.; Kim, E. H.; Jiang, X.; Jarrard, R. E.; Powers, M. S.; Kirchhoff, A. M.; Salvador, T. K.; Chester, J. A.; Hockerman, G. H.; Colby, D. A. J. Med. Chem. 2013, 56, 2456–2465. DOI:10.1021/jm301805e




21. “Amidinate Salt of Hexafluoroacetone Hydrate for the Preparation of Fluorinated Compounds by the Release of Trifluoroacetate.” Riofski, M. V.; Hart, A. D.; Colby, D. A. Org. Lett. 2013, 15, 208–211. DOI:10.1021/ol303291x
      • commercialized by Sigma-Aldrich (product #L511315)
      • listed in the Sigma-Aldrich Product Portal link
      • press announcement in Yahoo Finance link
      • press announcement in the Wall Street Journal Online link
      • recognized through 2013 Purdue President's Inventors Recognition Reception
      • press announcement in Morningstar link
      • article in Purdue Research Foundation News link
      • press announcement in RxTimes link
      • featured in the Purdue College of Pharmacy E-Newsletter, May 2013. link
      • abstract listed on organic-chemistry.org. link




20. “Amino-derivatives of the Sesquiterpene Lactone Class of Natural Products as Prodrugs.” Woods, J. R.; Mo, H.; Bieberich, A. A.; Alavanja, T.; Colby, D. A. MedChemComm 2013, 4, 27–33. DOI:10.1039/c2md20172k
      • New Talent themed issue
      • highlighted in Focus on New Talent DOI:10.1039/C2MD90055F




19. “Cleaving Carbon–Carbon Bonds by the Release of Trifluoroacetate to Remodel Molecules and Assemble Fluorinated Structures.” Han C.; Kim, E. H.; Colby, D. A. Synlett 2012, 23, 1559–1563. DOI:10.1055/s-0031-1291156




18. “Fluorinated Amino-Derivatives of the Sesquiterpene Lactone, Parthenolide, as 19F NMR Probes in Deuterium-Free Environments” Woods, J. R.; Mo, H.; Bieberich, A. A.; Alavanja, T.; Colby, D. A. J. Med. Chem. 2011, 54, 7934–7941. DOI:10.1021/jm201114t




17. “Synthesis of α-Halo-α,α-Difluoromethyl Ketones by a Trifluoroacetate Release/Halogenation Protocol” John, J. P.; Colby, D. A. J. Org. Chem. 2011, 76, 9163–9168. DOI: 10.1021/jo2017179




16. “Exploiting the Facile Release of Trifluoroacetate for the α-Methylenation of the Sterically Hindered Carbonyl Groups on (+)-Sclareolide and (–)-Eburnamonine.” Riofski, M. V.; John, J. P.; Zheng, M. M.; Kirshner, J.; Colby, D. A. J. Org. Chem. 2011, 76, 3676–3683. DOI:10.1021/jo102114f




15. “Cleavage of Carbon–Carbon Bonds through the Mild Release of Trifluoroacetate: Generation of α,α-Difluoroenolates for Aldol Reactions” Han, C.; Kim, E. H.; Colby, D. A. J. Am. Chem. Soc. 2011, 130, 5802–5805. DOI:10.1021/ja202213f
      • featured as a SynStory in SynForm 2011, 07, A62–A63. DOI:10.1055/s-0030-1260594
      • featured as a SynPact in Synlett 2012, 23, 1559–1563. DOI:10.1055/s-0031-1291156



14. “The Natural Products, Parthenolide and Andrographolide, Exhibit Anti-Cancer Stem Cell Activity in Multiple Myeloma.” Gunn, E. J.; Williams, J. T.; Huynh, D. T.; Iannotti, M. J.; Han, C.; Barrios, F. J.; Kendall, S.; Glackins, C. A.; Colby, D. A.; Kirshner, J. Leuk. Lymphoma 2011, 52, 1085–1097. DOI:10.3109/10428194.2011.555891




13. “Dialkylaluminum N,O-Dimethylhydroxylamine Complex as a Reagent to Mask Reactive Carbonyl Groups in situ from Nucleophiles.” Barrios, F. J.; Zhang, X.; Colby, D. A. Org. Lett. 2010, 12, 5588–5591. DOI:10.1021/ol102495v
      • highlighted in Org. Chem. Highlights 2011, September 12. link




12. “A Practical No-Deuterium NMR Method for the Rapid Determination of 1-Octanol/Water Partition Coefficients of Pharmaceutical Agents.” Mo., H.; Balko, K. M.; Colby, D. A. Bioorg. Med. Chem. Lett. 2010, 20, 6712–6715. DOI:10.1016/j.bmcl.2010.08.145




11. “Semisynthetic Derivatives of Sesquiterpene Lactones by Palladium-Catalyzed Arylation of the α-Methylene-γ-lactone Substructure” Han, C.; Barrios, F. J.; Riofski, M. V.; Colby, D. A. J. Org. Chem. 2009, 74, 7176–7179. DOI:10.1021/jo901533e





Postdoctoral research at The Scripps Research Institute


10. “Total Synthesis of Vinblastine, Vincristine, Related Natural Products, and Key Structural Analogues.” Ishikawa, H.; Colby, D. A.; Seto, S.; Va, P.; Tam, A.; Kakei, H.; Rayl, T. J.; Hwang, I.; Boger, D. L. J. Am. Chem. Soc. 2009, 131, 4904–4916.

9. “Direct Coupling of Catharanthine and Vindoline to Provide Vinblastine: Total Synthesis of (+)- and (–)-Vinblastine.” Ishikawa, H.; Colby, D. A.; Boger, D. L. J. Am. Chem. Soc. 2008, 130, 420–421.

8. “Total Synthesis and Evaluation of Cytostatin, its C10–C11 Diastereomers, and Additional Key Analogues: Impact on PP2A Inhibition.” Lawhorn, B. G.; Boga, S. B.; Wolkenberg, S. E.; Colby, D. A.; Guass, C. -M.; Swingle, M. R.; Amable, L.; Honkanen, R. E.; Boger, D. L. J. Am. Chem. Soc. 2006, 128, 16720–16732.


Graduate student research at the University of California, Irvine


7. “A Small Molecule Screen Identifies a Novel Compound that Induces a Homeotic Transformation in Hydra.” Glauber, K. M.; Dana, C. E.; Park, S. S.; Colby, D. A.; Noro, Y.; Fujisawa, T.; Chamberlin, A. R.; Steele, R. E. Development 2013, 140, 4788–4796.

6. “On the Successful Use of Inquiry-Driven Experiments in the Organic Chemistry Laboratory.” Mohrig, J. R.; Hammond, C. N.; Colby, D. A. J. Chem. Ed. 2007, 84, 992–998.

5. “Pharmacophore Identification: The Case of the Ser/Thr Protein Phosphatase Inhibitors.” Colby, D. A.; Chamberlin, A. R. Mini-Rev. Med. Chem. 2006, 6, 657–665.

4. “A New Model of the Tautomycin-PP1 Complex That Is Not Analogous to the Corresponding Okadaic Acid Structure.” Colby, D. A.; Liu, W.; Sheppeck, J. E.; Huang, H.-B.; Nairn, A. C.; Chamberlin A. R. Bioorg. Med. Chem. Lett. 2003, 13, 1601–1605.

3. “The Selective Inhibition of Phosphatases by Natural Toxins: the Anhydride Domain of Tautomycin is Not a Primary Factor in Controlling PP1/PP2A Selectivity.” Liu, W.; Sheppeck, J. E.; Colby, D. A.; Huang, H.-B.; Nairn, A. C.; Chamberlin A. R. Bioorg. Med. Chem. Lett. 2003, 13, 1597–1600.

Pharmacy student research at the University of Iowa


2. “Synthesis of the C10–C17 Fragment of Aurisides and Callipeltosides.” Romero-Ortega, M.; Colby, D. A.; Olivo, H. F. Tetrahedron Lett. 2002, 43, 6439–6441.

1. “Synthesis of New Open-Ring and homo-Epibatidine Analogues from Tropinone.” Olivo, H. F.; Colby, D. A.; Hemenway, M. S. J. Org. Chem. 1999, 64, 4966–4968.

Contact information:
phone: (662)915-1766
e-mail: dacolby@olemiss.edu
© 2020 David A. Colby